The 15q11.2 BP1–BP2 Microdeletion Syndrome: A Review
Patients with the 15q11.2 BP1–BP2 microdeletion can present with developmental and language delay, neurobehavioral disturbances and psychiatric problems. Autism, seizures, schizophrenia and mild dysmorphic features are less commonly seen. The 15q11.2 BP1–BP2 microdeletion involving four genes (i.e.,...
Main Authors: | , |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2015-02-01
|
Series: | International Journal of Molecular Sciences |
Subjects: | |
Online Access: | http://www.mdpi.com/1422-0067/16/2/4068 |
id |
doaj-fc9b98c704f348e8aeeb671bd4feb039 |
---|---|
record_format |
Article |
spelling |
doaj-fc9b98c704f348e8aeeb671bd4feb0392020-11-25T00:52:28ZengMDPI AGInternational Journal of Molecular Sciences1422-00672015-02-011624068408210.3390/ijms16024068ijms16024068The 15q11.2 BP1–BP2 Microdeletion Syndrome: A ReviewDevin M. Cox0Merlin G. Butler1Departments of Psychiatry & Behavioral Sciences, University of Kansas Medical Center, 3901 Rainbow Boulevard, MS 4015, Kansas City, KS 66160, USADepartments of Psychiatry & Behavioral Sciences, University of Kansas Medical Center, 3901 Rainbow Boulevard, MS 4015, Kansas City, KS 66160, USAPatients with the 15q11.2 BP1–BP2 microdeletion can present with developmental and language delay, neurobehavioral disturbances and psychiatric problems. Autism, seizures, schizophrenia and mild dysmorphic features are less commonly seen. The 15q11.2 BP1–BP2 microdeletion involving four genes (i.e., TUBGCP5, CYFIP1, NIPA1, NIPA2) is emerging as a recognized syndrome with a prevalence ranging from 0.57%–1.27% of patients presenting for microarray analysis which is a two to four fold increase compared with controls. Review of clinical features from about 200 individuals were grouped into five categories and included developmental (73%) and speech (67%) delays; dysmorphic ears (46%) and palatal anomalies (46%); writing (60%) and reading (57%) difficulties, memory problems (60%) and verbal IQ scores ≤75 (50%); general behavioral problems, unspecified (55%) and abnormal brain imaging (43%). Other clinical features noted but not considered as common were seizures/epilepsy (26%), autism spectrum disorder (27%), attention deficit disorder (ADD)/attention deficit hyperactivity disorder (ADHD) (35%), schizophrenia/paranoid psychosis (20%) and motor delay (42%). Not all individuals with the deletion are clinically affected, yet the collection of findings appear to share biological pathways and presumed genetic mechanisms. Neuropsychiatric and behavior disturbances and mild dysmorphic features are associated with genomic imbalances of the 15q11.2 BP1–BP2 region, including microdeletions, but with an apparent incomplete penetrance and variable expressivity.http://www.mdpi.com/1422-0067/16/2/406815q11.2 BP1–BP2 microdeletionBurnside-Butler syndromeclinical and behavioral phenotypechromosome breakpoints BP1 and BP2Prader-Willi and Angelman syndromeslanguage and motor delaysautismreview |
collection |
DOAJ |
language |
English |
format |
Article |
sources |
DOAJ |
author |
Devin M. Cox Merlin G. Butler |
spellingShingle |
Devin M. Cox Merlin G. Butler The 15q11.2 BP1–BP2 Microdeletion Syndrome: A Review International Journal of Molecular Sciences 15q11.2 BP1–BP2 microdeletion Burnside-Butler syndrome clinical and behavioral phenotype chromosome breakpoints BP1 and BP2 Prader-Willi and Angelman syndromes language and motor delays autism review |
author_facet |
Devin M. Cox Merlin G. Butler |
author_sort |
Devin M. Cox |
title |
The 15q11.2 BP1–BP2 Microdeletion Syndrome: A Review |
title_short |
The 15q11.2 BP1–BP2 Microdeletion Syndrome: A Review |
title_full |
The 15q11.2 BP1–BP2 Microdeletion Syndrome: A Review |
title_fullStr |
The 15q11.2 BP1–BP2 Microdeletion Syndrome: A Review |
title_full_unstemmed |
The 15q11.2 BP1–BP2 Microdeletion Syndrome: A Review |
title_sort |
15q11.2 bp1–bp2 microdeletion syndrome: a review |
publisher |
MDPI AG |
series |
International Journal of Molecular Sciences |
issn |
1422-0067 |
publishDate |
2015-02-01 |
description |
Patients with the 15q11.2 BP1–BP2 microdeletion can present with developmental and language delay, neurobehavioral disturbances and psychiatric problems. Autism, seizures, schizophrenia and mild dysmorphic features are less commonly seen. The 15q11.2 BP1–BP2 microdeletion involving four genes (i.e., TUBGCP5, CYFIP1, NIPA1, NIPA2) is emerging as a recognized syndrome with a prevalence ranging from 0.57%–1.27% of patients presenting for microarray analysis which is a two to four fold increase compared with controls. Review of clinical features from about 200 individuals were grouped into five categories and included developmental (73%) and speech (67%) delays; dysmorphic ears (46%) and palatal anomalies (46%); writing (60%) and reading (57%) difficulties, memory problems (60%) and verbal IQ scores ≤75 (50%); general behavioral problems, unspecified (55%) and abnormal brain imaging (43%). Other clinical features noted but not considered as common were seizures/epilepsy (26%), autism spectrum disorder (27%), attention deficit disorder (ADD)/attention deficit hyperactivity disorder (ADHD) (35%), schizophrenia/paranoid psychosis (20%) and motor delay (42%). Not all individuals with the deletion are clinically affected, yet the collection of findings appear to share biological pathways and presumed genetic mechanisms. Neuropsychiatric and behavior disturbances and mild dysmorphic features are associated with genomic imbalances of the 15q11.2 BP1–BP2 region, including microdeletions, but with an apparent incomplete penetrance and variable expressivity. |
topic |
15q11.2 BP1–BP2 microdeletion Burnside-Butler syndrome clinical and behavioral phenotype chromosome breakpoints BP1 and BP2 Prader-Willi and Angelman syndromes language and motor delays autism review |
url |
http://www.mdpi.com/1422-0067/16/2/4068 |
work_keys_str_mv |
AT devinmcox the15q112bp1bp2microdeletionsyndromeareview AT merlingbutler the15q112bp1bp2microdeletionsyndromeareview AT devinmcox 15q112bp1bp2microdeletionsyndromeareview AT merlingbutler 15q112bp1bp2microdeletionsyndromeareview |
_version_ |
1725242297723912192 |